Bayer Driving Progress in Radiology through Innovation in Research and Radiology AI
Bayer moves ahead with advancements across its comprehensive Radiology portfolio as well as expanded offering in its digital business and services. The company announced that new clinical and pre-clinical data for gadoquatrane, Bayer's novel investigational macrocyclic gadolinium-based contrast agent currently in Phase III clinical development, will be presented at the 2024 European Congress of Radiology (ECR) - taking place from February 28 to March 3, 2024, in Vienna, Austria. 
The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that support diagnoses for patients in the region. This includes one of the largest dermatology departments in the country, and gynaecology services that cover six hospitals. 
Highland Marketing has been looking ahead to 2024 and asking health tech leaders what they expect to see in health tech this year. The chair of the advisory board, Jeremy Nettle, argues that with a general election approaching, the NHS needs a period of stability to address the pressures it is facing.